BioForce Nanosciences Holdings, Inc. BFNH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 92.47% | 64.50% | -163.62% | -169.39% | -175.46% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -130.92% | -99.90% | -- | -- | -- |
| Change in Net Operating Assets | -28.90% | -4.15% | -1.00% | -0.44% | 0.19% |
| Cash from Operations | 42.84% | 27.21% | -6.37% | -28.97% | -59.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -40.18% | -42.34% | 21.91% | 47.52% | 43.45% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -75.00% | -- | -- | -100.00% | 7,900.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.96% | -50.90% | 5.85% | 25.55% | 60.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -350.00% | -156.49% | -150.00% | -190.00% | -- |